Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re

Journal of Nuclear Medicine

Volumn 41, Issue 5, 2000, Pages 887-895

  Zinn, Kurt R ^a,b   Buchsbaum, Donald J ^a   Chaudhuri, Tandra R ^a   Mountz, James M ^a   Grizzle, William E ^a   Rogers, Buck E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

99mTc; 188Re; Gene transfer; Imaging; Peptide; Somatostatin receptor

Indexed keywords

FLUORESCEIN; PEPTIDE; RHENIUM 188; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MONITORING; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOISOTOPE DECAY; REPORTER GENE; SCINTILLATION CAMERA; TUMOR XENOGRAFT;

ADENOVIRIDAE; ANIMALS; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PEPTIDES, CYCLIC; RADIOISOTOPES; RECEPTORS, SOMATOSTATIN; RHENIUM; TECHNETIUM; TUMOR CELLS, CULTURED;

EID: 0034019279     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Wiebe LI, Morin KW, Knaus EE. Radiopharmaceuticals to monitor gene transfer. Q J Nuc Med. 1997;41:79-89.
2. Bogdanov A Jr, Weissleder R. The development of in vivo imaging systems to study gene expression. Trends Biotechnol 1998;16:5-10.
3. Service RF. Molecular imaging: new probes open windows on gene expression, and more. Science. 1998;280:1010-1011.
4. Fehse B, Li Z, Schade UM, Uhde A, Zander AR. Impact of a new generation of gene transfer markers on gene therapy. Gene Ther. 1998;5:429-430.
5. Bennett J, Duan D, Engelhardt JF, Maguire AM. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci. 1997;38:2857-2863.
6. Contag PR, Olomu IN, Stevenson DK, Contag CH. Bioluminescent indicators in living mammals. Nat Med. 1998;4:245-247.
7. Contag CH, Spilman SD, Contag PR, et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol. 1997;66: 523-531.
8. Weissleder R, Tung CH, Mahmood U, Bogdanov A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 1999;17: 375-378.
9. Tjuvajev JG, Stockhammer G, Desai R, et al. Imaging the expression of transfected genes in vivo. Cancer Res. 1995;55:6126-6132.
10. Tjuvajev JG, Finn R, Watanabe K, et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res. 1996;56:4087-4095.
11. Tjuvajev JG, Avril N, Oku T, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 1998;58: 4333-4341.
12. 18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol. 1996;23:787-792.
13. 18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol. 1998;25:175-180.
14. Gambhir SS, Barrio JR, Wu L, et al. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med. 1998;39:2003-2011.
15. Gambhir SS, Barrio JR, Phelps ME, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Med Sci. 1999;96:2333-2338.
16. Gambhir SS, Barrio JR, Hershman HR, Phelps ME. Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol. 1999;26:481-490.
17. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4:1334-1336.
18. 124I]iodo-2′-deoxyuridine for functional PET imaging of cell proliferation. Nucl Med Biol. 1998;25:359-365.
19. Herschman HR, Sharfstein S, Gambhir SS, et al. In vivo imaging of gene expression associated with cell replication [abstract]. J Nucl Med. 1997;38:250P.
20. 2 receptor as a reporter gene in living animals. Gene Ther. 1999;6:785-791.
21. Weissleder R, Simonova M, Bogdanova A, Bredow S, Enochs WS, Bogdanov A. MR imaging and scintigraphy of gene expression through melanin induction. Radiology. 1997;204:425-429.
22. Pearson D, Lister-James J, McBride W, et al. Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies. J Med Chem. 1996;39:1361-1371.
23. Vallabhajosula S, Moyer BR, Lister-James J, et al. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J Nucl Med. 1996;37:1016-1022.
24. 99mTc-P829. Cancer Res. 1998;58:1850-1859.
25. Blum JE, Handmaker H, Rinne NA. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules. Chest. 1999;115:224-232.
26. 1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res. 1999;5:383-393.
27. Falck-Pedersen E, Heinflink M, Alvira M, Nussenzveig DR, Gershengorn MC. Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific. Mol Pharmacol. 1999;45:684-689.
28. Knapp FF, Beets AL, Guhlke S, et al. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res. 1997;17: 1783-1796
29. Knapp FF. Rhenium-188: a generator-derived radioisotope for cancer therapy. Cancer Biother Radiopharm. 1998;13:337-349.
30. Munson P, Rodbard D. Ligand: a versatile computerized approach for characterizalion of ligand binding systems. Anal Biochem. 1980;107:220-239.
31. Grizzle WE, Myers RB, Manne U, Stockard CR, Harkins LE, Srivastava S. Factors affecting immunohistochemical evaluation of biomarker expression in neoplasia. In: Hanausek M, Walaszek Z, eds. John Walker's Methods in Molecular Medicine: Tumor Marker Protocols. Totowa, NJ: Humana Press; 1998:161-179.
32. Bernard BF, Krenning EP, Breeman WA, et al. D-Lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med. 1997;38:1929-1933.
33. Behr TM, Sharkey RM, Sgouros G, et al. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry. Cancer. 1997;80:2591-2610.
34. Bramson J, Hitt M, Gallichan WS, Rosenthal KL, Gauldie J, Graham FL. Construction of a double recombinant adenoviral vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum Gene Ther. 1996;7:333-342.
35. Emtage PC, Wan Y, Bramson JL, Graham FL, Gauldie J. A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model. J Immunol. 1998;160:2531-2538.